Find your next paid study

Medstar Health Research InstituteNCT07445932

~$10 – $1,125

Actual pay is set by the research site.

Sedentary Middle Age and Older Aged Adults

Improving Exercise Adherence With App Technology for At-Risk Adults Living in Rural Kansas and Nebraska

Alzheimer's disease and related dementias are a public health crisis impacting individuals across the world. In the United States, adults living in rural areas…

Creighton UniversityNCT07171255

Actual pay is set by the research site.

Multiple System Atrophy (MSA)Healthy AdultParkinson Disease

Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

This is a single-center, open-label clinical study designed to evaluate the imaging characteristics and safety of \[¹⁸F\]MODAG-009 in participants with Parkins…

Cervical Intraepithelial Neoplasia Grade 2/3Human Papilloma Virus Infection Type 16

~$500 – $10,500

Actual pay is set by the research site.

MODAG GmbHNCT07640555

Phase 2

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

The purpose of this Phase 2 study is to compare the effects of administering the PVX4 combination device biologic product (pBI-4 DNA vaccine via electroporatio…

PapiVax Biotech, Inc.NCT07454915

~$75 – $2,800

Actual pay is set by the research site.

Metastatic Prostate CancerMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic Cancer

A Phase 1/2 Immunotherapy Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab in Patients with Advanced Solid Malignancies

The purpose of this Phase 1/2 study is to test the overall safety, tolerability, and effectiveness of the combination investigational drugs evofosfamide, zalif…

~$150 – $4,500

Actual pay is set by the research site.

ImmunoGenesisNCT06782555

Head and Neck Cancer (H&N)

Speed of Processing Training to Improve Cognitive Functioning and Driving Performance in Head and Neck Cancer Survivors

The goal of the study is to understand how well cognitive training improves reaction time in people with head and neck cancer (HNC). Aim 1. Evaluate the prelim…

University of Alabama at BirminghamNCT07740616

Actual pay is set by the research site.

Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more

A Multicenter Open-Label Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.

Revolution Medicines, Inc.NCT05379985

~$150 – $4,200

Actual pay is set by the research site.

Non-muscle-invasive Bladder Cancer

A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer

This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety an…

SURGE TherapeuticsNCT05710848

~$150 – $4,200

Actual pay is set by the research site.

Medication Refractory Epilepsy Patients With Electrodes Already Implanted Based on Clinical Criteria for Standard Monitoring

Model-based Electrical Brain Stimulation

Neuropsychiatric disorders are a leading cause of disability worldwide with depressive disorders being one of the most disabling among them. Also, millions of …

University of Southern CaliforniaNCT05327387

Actual pay is set by the research site.

Locally Advanced or Metastatic Melanoma

MEL-212: A Phase I Proof-of-Concept Study of CBL0137 (Curaxin) Combined With Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma

Phase I, open label, dose-escalation, and safety study designed to assess the safety and biologic activity of the investigational agent CBL0137 in combination …

Fox Chase Cancer CenterNCT05498792

~$150 – $3,000

Actual pay is set by the research site.

Adverse Childhood Experiences

A Multi-Component Intervention to Strengthen Families With Adverse Childhood Experiences (ACEs)

Prior research suggests that it is possible to improve health outcomes in children with ACEs through multi-component interventions. The challenge for most comm…

Loma Linda UniversityNCT05388864

Actual pay is set by the research site.

Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more

A Phase 1a/1b, Multicenter, Open-label, Dose Escalation/Expansion, Multiple-dose Study to Evaluate the Safety and Activity of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

A phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients with locally …